From the mediterranean to the sea of Japan: The transcontinental odyssey of autoinflammatory diseases

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Rigante, Donato ^a   Frediani, Bruno ^b   Galeazzi, Mauro ^b   Cantarini, Luca ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANAKINUMAB; COLCHICINE; CORTICOSTEROID; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; INTERLEUKIN 1; INTERLEUKIN 6; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR;

AUTOINFLAMMATORY DISEASE; CINCA SYNDROME; CORTICOSTEROID THERAPY; FAMILIAL MEDITERRANEAN FEVER; GENETIC DRIFT; GRANULOMATOSIS; HUMAN; INNATE IMMUNITY; KIDNEY AMYLOIDOSIS; LOSS OF FUNCTION MUTATION; MEVALONATE KINASE DEFICIENCY; PAPA SYNDROME; PATHOPHYSIOLOGY; RECURRENT FEVER; REVIEW; SKIN DISEASE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; AUTOIMMUNE DISEASES; EPIDEMIC; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; INFLAMMATION; JAPAN; RISK FACTOR; SOUTHERN EUROPE; STATISTICS AND NUMERICAL DATA; AUTOIMMUNE DISEASE; STATISTICS;

AUTOIMMUNE DISEASES; DISEASE OUTBREAKS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; INFLAMMATION; JAPAN; MEDITERRANEAN REGION; RISK FACTORS;

EID: 84881503457     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/485103     Document Type: Review

References (53)

1. Hashkes P. J., Toker O., Autoinflammatory syndromes. Pediatric Clinics of North America 2012 59 2 447 470 2-s2.0-84860516763 10.1016/j.pcl.2012.03.005
2. Lamkanfi M., Dixit V. M., Inflammasomes and their roles in health and disease. Annual Review of Cell and Developmental Biology 2012 28 137 161 10.1146/annurev-cellbio-101011-155745
3. Rigante D., The fresco of autoinflammatory diseases from the pediatric perspective. Autoimmunity Reviews 2012 11 5 348 356 2-s2.0-84857500409 10.1016/j.autrev.2011.10.008
4. Ben-Chetrit E., Touitou I., Familial Mediterranean fever in the world. Arthritis Care and Research 2009 61 10 1447 1453 2-s2.0-70349774428 10.1002/art.24458
5. Guz G., Kanbay M., Ozturk M. A., Current perspectives on familial Mediterranean fever. Current Opinion in Infectious Diseases 2009 22 3 309 315 2-s2.0-65549097567 10.1097/QCO.0b013e328329d15e
6. Ben-Chetrit E., Levy M., Familial Mediterranean fever. The Lancet 1998 351 9103 659 664 2-s2.0-0032574208 10.1016/S0140-6736(97)09408-7 (Pubitemid 28098460)
7. Rigante D., La Torraca I., Ansuini V., Compagnone A., Sallì A., Stabile A., The multi-face expression of familial Mediterranean fever in the child. European Review for Medical and Pharmacological Sciences 2006 10 4 163 171 2-s2.0-33748568520 (Pubitemid 44468940)
8. Cattan D., Familial Mediterranean fever: is low mortality from tuberculosis a specific advantage for MEFV mutations carriers? Mortality from tuberculosis among Muslims, Jewish, French, Italian and Maltese patients in Tunis (Tunisia) in the first half of the 20th century. Clinical and Experimental Rheumatology 2003 21 supplement 30 S53 S54 (Pubitemid 37193100)
9. Papadopoulos V. P., Giaglis S., Mitroulis I., Ritis K., The population genetics of familial Mediterranean fever: a meta-analysis study. Annals of Human Genetics 2008 72 part 6 752 761 2-s2.0-54049125765 10.1111/j.1469-1809.2008. 00471.x
10. Jalkh N., Génin E., Chouery E., Delague V., Medlej-Hashim M., Idrac C., Mégarbané A., Serre J., Familial Mediterranean fever in Lebanon: founder effects for different MEFV mutations. Annals of Human Genetics 2008 72 1 41 47 2-s2.0-38049045185 10.1111/j.1469-1809.2007.00386.x
11. Tsuchiya-Suzuki A., Yazaki M., Nakamura A., Yamazaki K., Agematsu K., Matsuda M., Ikeda S., Clinical and genetic features of familial Mediterranean fever in Japan. Journal of Rheumatology 2009 36 8 1671 1676 2-s2.0-68849120943 10.3899/jrheum.081278
12. Ebrahimi-Fakhari D., Schnland S. O., Hegenbart U., Lohse P., Beimler J., Wahlster L., Ho A. D., Lorenz H. M., Blank N., Familial Mediterranean fever in Germany: clinical presentation and amyloidosis risk. Scandinavian Journal of Rheumatology 2013 42 1 52 58 10.3109/03009742.2012.714796
13. Touitou I., Sarkisian T., Medlej-Hashim M., Tunca M., Livneh A., Cattan D., Yalçinkaya F., Özen S., Majeed H., Ozdogan H., Kastner D., Booth D., Ben-Chetrit E., Pugnère D., Michelon C., Séguret F., Gershoni-Baruch R., Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis and Rheumatism 2007 56 5 1706 1712 2-s2.0-34248571365 10.1002/art.22507 (Pubitemid 46764102)
14. Sohar E., Gafni J., Pras M., Heller H., Familial Mediterranean fever. A survey of 470 cases and review of the literature. The American Journal of Medicine 1967 43 2 227 253 2-s2.0-0014118417
15. Samuels J., Aksentijevich I., Torosyan Y., Centola M., Deng Z., Sood R., Kastner D. L., Familial Mediterranean fever at the millennium clinical spectrum, ancient mutations, and a survey of 100 American referrals to the national institutes of health. Medicine 1998 77 4 268 297 2-s2.0-0031814513 10.1097/00005792-199807000-00005 (Pubitemid 28376140)
16. Livneh A., Langevitz P., Zemer D., Zaks N., Kees S., Lidar T., Migdal A., Padeh S., Pras M., Criteria for the diagnosis of familial Mediterranean fever. Arthritis and Rheumatism 1997 40 10 1879 1885 2-s2.0-0030783102 10.1002/art.1780401023 (Pubitemid 27452541)
17. Soriano A., Manna R., Familial Mediterranean fever: new phenotypes. Autoimmunity Reviews 2012 12 1 31 37 10.1016/j.autrev.2012.07.019
18. Rigante D., La Torraca I., Avallone L., Pugliese A. L., Gaspari S., Stabile A., The pharmacologic basis of treatment with colchicine in children with familial Mediterranean fever. European Review for Medical and Pharmacological Sciences 2006 10 4 173 178 2-s2.0-33748574940 (Pubitemid 44468941)
19. Roldan R., Ruiz A. M., Miranda M. D., Collantes E., Anakinra: new therapeutic approach in children with familial Mediterranean fever resistant to colchicine. Joint Bone Spine 2008 75 4 504 505 2-s2.0-46449134465 10.1016/j.jbspin.2008.04.001
20. van der Meer J. W. M., Vossen J. M., Radl J., van Nieuwkoop J. A., Meyer C. J., Lobatto S., van Furth R., Hyperimmunoglobulinemia D and periodic fever: a new syndrome. The Lancet 1984 1 8386 1087 1090 2-s2.0-0021287627 (Pubitemid 14100804)
21. Lachmann H. J., Clinical immunology review series: an approach to the patient with a periodic fever syndrome. Clinical and Experimental Immunology 2011 165 3 301 309 2-s2.0-79961015780 10.1111/j.1365-2249.2011.04438.x
22. Vuch J., Marcuzzi A., Bianco A. M., Tommasini A., Zanin V., Crovella S., Evolutionary hypothesis of the mevalonate kinase deficiency. Medical Hypotheses 2013 80 1 67 69 10.1016/j.mehy.2012.10.016
23. Drenth J. P. H., Haagsma C. J., van der Meer J. W. M., Weemaes C. M. R., Bijlsma J. W. J., de Graeff-Meeder E. R., Alcalay M., Chapelon-Abric C., Kahn M. F., Prieur A. M., Sibilia J., Powell R. J., Topaloglu R., Saatci U., Scolozzi R., Lazzarin P., Monciotti C. M., Demonty J., Jilek D., Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. Medicine 1994 73 3 133 144 2-s2.0-0028026953
24. Ammouri W., Cuisset L., Rouaghe S., Rolland M.-., Delpech M., Grateau G., Ravet N., Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology 2007 46 10 1597 1600 2-s2.0-34848837371 10.1093/rheumatology/kem200 (Pubitemid 47500578)
25. Rigante D., Ansuini V., Bertoni B., Pugliese A. L., Avallone L., Federico G., Stabile A., Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome. Rheumatology International 2006 27 1 97 100 2-s2.0-33750489045 10.1007/s00296-006-0164-x (Pubitemid 44655757)
26. Bodar E. J., Kuijk L. M., Drenth J. P. H., van der Meer J. W. M., Simon A., Frenkel J., On-demand anakinra treatment is effective in mevalonate kinase deficiency. Annals of the Rheumatic Diseases 2011 70 12 2155 2158 2-s2.0-84860389029 10.1136/ard.2011.149922
27. Drenth J. P. H., van Deuren M., van der Ven-Jongekrijg J., Schalkwijk C. G., van der Meer J. W. M., Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood 1995 85 12 3586 3593 2-s2.0-0029009413
28. Aksentijevich I., Galon J., Soares M., Mansfield E., Hull K., Oh H.-., Goldbach-Mansky R., Dean J., Athreya B., Reginato A. J., Henrickson M., Pons-Estel B., O'Shea J. J., Kastner D. L., The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. The American Journal of Human Genetics 2001 69 2 301 314 2-s2.0-0034926933 10.1086/321976 (Pubitemid 32695203)
29. Nedjai B., Hitman G. A., Church L. D., Minden K., Whiteford M. L., McKee S., Stjernberg S., Pettersson T., Ranki A., Hawkins P. N., Arkwright P. D., McDermott M. F., Turner M. D., Differential cytokine secretion results from p65 and c-Rel NF- B subunit signaling in peripheral blood mononuclear cells of TNF receptor-associated periodic syndrome patients. Cellular Immunology 2011 268 2 55 59 2-s2.0-79954418639 10.1016/j.cellimm.2011.02.007
30. Ryan J. G., Goldbach-Mansky R., The spectrum of autoinflammatory diseases: recent bench to bedside observations. Current Opinion in Rheumatology 2008 20 1 66 75 2-s2.0-40349112838 10.1097/BOR.0b013e3282f1bf4b (Pubitemid 351339434)
31. Stojanov S., McDermott M. F., The tumour necrosis factor receptor-associated periodic syndrome: current concepts. Expert Reviews in Molecular Medicine 2005 7 22 1 18 2-s2.0-32844473310 10.1017/S1462399405009749
32. Dinc A., Erdem H., Rowczenio D., Simsek I., Pay S., Bahce M., Lachmann H., Autosomal dominant periodic fever with AA amyloidosis: tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Turkish family. Journal of Nephrology 2005 18 5 626 629 2-s2.0-29244456738 (Pubitemid 41824487)
33. Cantarini L., Rigante D., Lucherini O. M., Cimaz R., Pasini F. L., Baldari C. T., Benucci M., Simonini G., Di Sabatino V., Brizi M. G., Galeazzi M., Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature. International Journal of Immunopathology and Pharmacology 2010 23 3 701 707 2-s2.0-78149272003
34. Gattorno M., Pelagatti M. A., Meini A., Obici L., Barcellona R., Federici S., Buoncompagni A., Plebani A., Merlini G., Martini A., Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis and Rheumatism 2008 58 5 1516 1520 2-s2.0-43949128071 10.1002/art.23475 (Pubitemid 351705941)
35. Cantarini L., Lucherini O. M., Frediani B., Brizi M. G., Bartolomei B., Cimaz R., Galeazzi M., Rigante D., Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes. International Journal of Immunopathology and Pharmacology 2011 24 4 827 836 2-s2.0-84856571891
36. Maksimovic L., Stirnemann J., Caux F., Ravet N., Rouaghe S., Cuisset L., Letellier E., Grateau G., Morin A., Fain O., New CIAS1 mutation and anakinra efficacy in overlapping of Muckle-Wells and familial cold autoinflammatory syndromes. Rheumatology 2008 47 3 309 310 2-s2.0-39449098500 10.1093/rheumatology/kem318 (Pubitemid 351267196)
37. Aksentijevich I., Putnam C. D., Remmers E. F., Mueller J. L., Le J., Kolodner R. D., Moak Z., Chuang M., Austin F., Goldbach-Mansky R., Hoffman H. M., Kastner D. L., The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis and Rheumatism 2007 56 4 1273 1285 2-s2.0-34247252063 10.1002/art.22491 (Pubitemid 46608652)
38. Yu J. R., Leslie K. S., Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response. Current Allergy and Asthma Reports 2011 11 1 12 20 2-s2.0-79551533377 10.1007/s11882-010-0160-9
39. Rigante D., Leone A., Marrocco R., Laino M. E., Stabile A., Long-term response after 6-year treatment with anakinra and onset of focal bone erosion in neonatal-onset multisystem inflammatory disease (NOMID/CINCA). Rheumatology International 2011 31 12 1661 1664 2-s2.0-83555160888 10.1007/s00296-010-1787-5
40. Lachmann H. J., Kone-Paut I., Kuemmerle-Deschner J. B., Leslie K. S., Hachulla E., Quartier P., Gitton X., Widmer A., Patel N., Hawkins P. N., Canakinumab in CAPS Study Group, Use of canakinumab in the cryopyrin-associated periodic syndrome. The New England Journal of Medicine 2009 360 23 2416 2425 2-s2.0-66649102432 10.1056/NEJMoa0810787
41. Rigante D., Cantarini L., Monogenic autoinflammatory syndromes at a dermatological level. Archives of Dermatological Research 2011 303 6 375 380 2-s2.0-79960712082 10.1007/s00403-011-1134-z
42. Tallon B., Corkill M., Peculiarities of PAPA syndrome. Rheumatology 2006 45 9 1140 1143 2-s2.0-33749621794 10.1093/rheumatology/kei178 (Pubitemid 44542104)
43. Demidowich A. P., Freeman A. F., Kuhns D. B., Aksentijevich I., Gallin J. I., Turner M. L., Kastner D. L., Holland S. M., Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne). Arthritis and Rheumatism 2012 64 6 2022 2027 10.1002/art.34332
44. Aksentijevich I., Masters S. L., Ferguson P. J., An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. The New England Journal of Medicine 2009 360 2426 2437 10.1056/NEJMoa0807865
45. Blau E. B., Familial granulomatous arthritis, iritis, and rash. Journal of Pediatrics 1985 107 5 689 693 2-s2.0-0022213722 (Pubitemid 16250502)
46. Sfriso P., Caso F., Tognon S., Galozzi P., Gava A., Punzi L., Blau syndrome, clinical and genetic aspects. Autoimmunity Reviews 2012 12 1 44 51 10.1016/j.autrev.2012.07.028
47. Kanazawa N., Nakajo-Nishimura syndrome: an autoinflammatory disorder showing pernio-like rashes and progressive partial lipodystrophy. Allergology International 2012 61 2 197 206 10.2332/allergolint.11-RAI-0416
48. Torrelo A., Patel S., Colmenero I., Gurbindo D., Lendínez F., Hernández A., López-Robledillo J. C., Dadban A., Requena L., Paller A. S., Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome. Journal of the American Academy of Dermatology 2010 62 3 489 495 2-s2.0-76249121423 10.1016/j.jaad.2009.04.046
49. Cañete J. D., Aróstegui J. I., Queiró R., Sanmartí R., Ballina J., Bosch X., Yagüe J., Association of intermittent hydrarthrosis with MEFV gene mutations. Arthritis and Rheumatism 2006 54 7 2334 2335 (Pubitemid 44051095)
50. Piastra M., Pietrini D., Conti G., de Rosa G., Rigante D., Sudden shock from capillary leak. The Lancet 2012 379 9819 976 2-s2.0-84858017064 10.1016/S0140-6736(11)61819-9
51. Cañete J. D., Arostegui J. I., Queiró R., Gratacós J., Hernández M. V., Larrosa M., Alperí M., Moll C., Rius J., Sanmartí R., Yagüe J., An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism. Arthritis and Rheumatism 2007 56 8 2784 2788 2-s2.0-34547748859 10.1002/art.22755 (Pubitemid 47237298)
52. Haar N. T., Lachmann H., Ozen S., Treatment of autoinflammatory diseases: results from the eurofever registry and a literature review. Annals of the Rheumatic Diseases 2013 72 5 678 685 10.1136/annrheumdis-2011-201268
53. Migita K., Uehara R., Nakamura Y., Yasunami M., Tsuchiya-Suzuki A., Yazaki M., Nakamura A., Masumoto J., Yachie A., Furukawa H., Ishibashi H., Ida H., Yamazaki K., Kawakami A., Agematsu K., Familial Mediterranean fever in Japan. Medicine 2012 91 6 337 343 10.1097/MD.0b013e318277cf75